GSK3965193
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GSK3965193, covering 2025-08-19 to 2026-06-16. Get the full timeline:
Most recent: Clinical Trial Results: Study of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B Infection [Phase 1, Phase 2]